Roche Chairman still expects diagnostic products to be impacted by US tariffs

格隆汇2026/03/07 09:23

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Gelonghui, March 7th｜Roche Group Chairman Severin Schwan stated on Saturday that Roche expects its agreement with the US government will exempt its pharmaceuticals from the current round of import tariffs. However, its diagnostics division still faces risks and may be subject to new tariffs after the initial 150-day period expires. Schwan said that Roche's diagnostics division had sales close to 14 billion Swiss francs in 2025, with most of its tests and instruments exported to the US from Switzerland and other European countries.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Kevin Hassett, Director of the White House National Economic Council, stated that the recent substantial decline in technology stocks does not indicate a comprehensive sell-off risk for the AI industry. He acknowledged that some enterprises are indeed burdened with significant debt, which warrants attention. However, he also pointed out that there are many financially strong companies within the industry that hold both equity and debt in related firms; these companies may be poised to acquire or provide funding support when opportunities arise.

华尔街见闻•2026/11/02 20:01